Watch Demo

Global X-Ray Crystallography Industry

Global X-Ray Crystallography Industry

  • Publish Date:October 2022

  • Number of Pages:194

  • Report ID:5960552

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 4950

Summary

Abstract:

What’s New for 2022?

Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global X-Ray Crystallography Market to Reach $1.3 Billion by 2027

In the changed post COVID-19 business landscape, the global market for X-Ray Crystallography estimated at US$598.3 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 11.3% over the analysis period 2020-2027. Pharmaceutical, one of the segments analyzed in the report, is projected to record a 10.9% CAGR and reach US$611 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biotechnology segment is readjusted to a revised 12.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $173.3 Million, While China is Forecast to Grow at 10.6% CAGR

The X-Ray Crystallography market in the U.S. is estimated at US$173.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$218.9 Million by the year 2027 trailing a CAGR of 10.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Other End-Uses Segment to Record 9.6% CAGR

In the global Other End-Uses segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$65.1 Million in the year 2020 will reach a projected size of US$122.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 41 Featured) -
C4X Discovery
Charles River Laboratories International, Inc.
Crelux
Rigaku Corporation
Rosalind

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
X-ray Crystallography - Global Key Competitors Percentage
Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for X-Ray
Crystallography by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for X-Ray Crystallography by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for X-Ray Crystallography by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Pharmaceutical by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Pharmaceutical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Pharmaceutical by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Biotechnology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Biotechnology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Biotechnology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 13: World X-Ray Crystallography Market Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 14: USA Recent Past, Current & Future Analysis for X-Ray
Crystallography by End-Use - Pharmaceutical, Biotechnology and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 15: USA Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 16: USA 15-Year Perspective for X-Ray Crystallography by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

CANADA
Table 17: Canada Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 18: Canada Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 19: Canada 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

JAPAN
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 20: Japan Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 21: Japan Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 22: Japan 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

CHINA
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 23: China Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 24: China Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 25: China 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

EUROPE
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 26: Europe Recent Past, Current & Future Analysis for
X-Ray Crystallography by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 27: Europe Historic Review for X-Ray Crystallography by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 28: Europe 15-Year Perspective for X-Ray Crystallography
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2021 & 2027

Table 29: Europe Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 30: Europe Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 31: Europe 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

FRANCE
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 32: France Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 33: France Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 34: France 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

GERMANY
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 35: Germany Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 36: Germany Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 37: Germany 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

ITALY
Table 38: Italy Recent Past, Current & Future Analysis for
X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 39: Italy Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 40: Italy 15-Year Perspective for X-Ray Crystallography
by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

UNITED KINGDOM
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 41: UK Recent Past, Current & Future Analysis for X-Ray
Crystallography by End-Use - Pharmaceutical, Biotechnology and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 42: UK Historic Review for X-Ray Crystallography by
End-Use - Pharmaceutical, Biotechnology and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 43: UK 15-Year Perspective for X-Ray Crystallography by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Biotechnology and Other End-Uses for the Years
2012, 2021 & 2027

REST OF EUROPE
Table 44: Rest of Europe Recent Past, Current & Future Analysis
for X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 45: Rest of Europe Historic Review for X-Ray
Crystallography by End-Use - Pharmaceutical, Biotechnology and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 46: Rest of Europe 15-Year Perspective for X-Ray
Crystallography by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical, Biotechnology and Other End-Uses for
the Years 2012, 2021 & 2027

ASIA-PACIFIC
X-Ray Crystallography Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 47: Asia-Pacific Recent Past, Current & Future Analysis
for X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 48: Asia-Pacific Historic Review for X-Ray
Crystallography by End-Use - Pharmaceutical, Biotechnology and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 49: Asia-Pacific 15-Year Perspective for X-Ray
Crystallography by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical, Biotechnology and Other End-Uses for
the Years 2012, 2021 & 2027

REST OF WORLD
Table 50: Rest of World Recent Past, Current & Future Analysis
for X-Ray Crystallography by End-Use - Pharmaceutical,
Biotechnology and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 51: Rest of World Historic Review for X-Ray
Crystallography by End-Use - Pharmaceutical, Biotechnology and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 52: Rest of World 15-Year Perspective for X-Ray
Crystallography by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical, Biotechnology and Other End-Uses for
the Years 2012, 2021 & 2027

IV. COMPETITION

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.